Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

The effects of cannabis abstinence on anhedonic behaviour on people with co-morbid Major Depressive Disorder and Cannabis Use Disorder

EF 2022-23

Résumé
Major depressive disorder (MDD) is a highly prevalent and debilitating psychiatric disorder, and one of the most impactful contributors to the global burden of disease. Cannabis use may have harmful consequences on mental health outcomes, and with cannabis use disorder (CUD) being more common in those with MDD than the general population, cannabis use and related harms exacerbate this burden. Those with co-morbid CUD and MDD have more significant mood symptoms, cognitive problems, and reduced quality of life, however, the nature of the relationship between CUD and MDD remains unclear. There are few, if any, controlled clinical studies that assess the effects of cannabis use versus cannabis abstinence. Anhedonia, which is a loss of interest in or pleasure from previously rewarding activities, is a common symptom of MDD, and plays a large role in the reward processes that are implicated in substance use disorders (SUDs). Our preliminary data suggests that 28 days of cannabis abstinence significantly reduces depressive and anhedonic symptoms in people with MDD. This proposed study will assess 28 days of cannabis abstinence on anhedonia, other clinical symptoms, and cognition, in individuals with CUD and MDD. Furthermore, to validate the effectiveness of contingency models to treat SUDs, one group will receive a bonus of $300 if they achieve 28 days of abstinence, while the other group will not receive this bonus. Lastly, both males and females will be recruited, to investigate sex differences in study outcome measures. This study is highly relevant to understanding causal effects of cannabis use and abstinence on clinical outcomes of individuals who have MDD and CUD, and can help inform treatments for MDD and CUD, which will have considerable public health implications.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
485888
Name
Zhang Yunyi
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The effects of cannabis abstinence on anhedonic behaviour on people with co-morbid Major Depressive Disorder and Cannabis Use Disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Addiction; Anhedonia; Cannabis; Cannabis Use Disorder; Depression; Drug Abuse; Major Depressive Disorder; Mood Disorders; Reward Processing; Substance Use Disorders
Abstract
Major depressive disorder (MDD) is a highly prevalent and debilitating psychiatric disorder, and one of the most impactful contributors to the global burden of disease. Cannabis use may have harmful consequences on mental health outcomes, and with cannabis use disorder (CUD) being more common in those with MDD than the general population, cannabis use and related harms exacerbate this burden. Those with co-morbid CUD and MDD have more significant mood symptoms, cognitive problems, and reduced quality of life, however, the nature of the relationship between CUD and MDD remains unclear. There are few, if any, controlled clinical studies that assess the effects of cannabis use versus cannabis abstinence. Anhedonia, which is a loss of interest in or pleasure from previously rewarding activities, is a common symptom of MDD, and plays a large role in the reward processes that are implicated in substance use disorders (SUDs). Our preliminary data suggests that 28 days of cannabis abstinence significantly reduces depressive and anhedonic symptoms in people with MDD. This proposed study will assess 28 days of cannabis abstinence on anhedonia, other clinical symptoms, and cognition, in individuals with CUD and MDD. Furthermore, to validate the effectiveness of contingency models to treat SUDs, one group will receive a bonus of $300 if they achieve 28 days of abstinence, while the other group will not receive this bonus. Lastly, both males and females will be recruited, to investigate sex differences in study outcome measures. This study is highly relevant to understanding causal effects of cannabis use and abstinence on clinical outcomes of individuals who have MDD and CUD, and can help inform treatments for MDD and CUD, which will have considerable public health implications.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhang, Yunyi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~